Head-to-Head Comparison of Psoriasis Severity Scoring Systems: Assessing Reliability, Sensitivity, and Clinical Utility

Abstract

Background: Accurate assessment of psoriasis severity is essential for guiding therapeutic decisions and evaluating treatment outcomes. Multiple scoring systems are available, including the Psoriasis Area and Severity Index (PASI), Body Surface Area (BSA), Lattice Physician Global Assessment (LPGA), and Psoriasis Quality of Life Index (PQLI). However, differences in reliability, sensitivity, and clinical utility necessitate direct comparison to determine their relative strengths and limitations.

Aim: To perform a head-to-head comparison of commonly used psoriasis severity scoring systems with respect to reliability, responsiveness, correlation, and clinical applicability.

Methods: This observational study included patients with clinically diagnosed psoriasis. Disease severity was assessed using PASI, BSA, LPGA, and PQLI. Descriptive statistics were calculated for baseline characteristics. Correlation between scoring systems was evaluated using Pearson’s or Spearman’s correlation coefficients as appropriate. Inter-observer reliability was assessed using the Intraclass Correlation Coefficient (ICC). Responsiveness to treatment was determined by comparing baseline and post-treatment scores, and effect sizes were calculated. A p-value <0.05 was considered statistically significant.

Results: Clinician-based scoring systems demonstrated strong inter-correlation, particularly between PASI and BSA, as well as PASI and LPGA. PASI showed excellent inter-observer reliability and the highest sensitivity to change following treatment. Moderate correlation was observed between objective severity indices and PQLI, indicating that quality-of-life impairment does not always directly parallel clinical severity. All scoring systems demonstrated statistically significant improvement following therapy.

Conclusion: PASI remains a reliable and highly responsive instrument for assessing psoriasis severity. However, simplified tools such as BSA and LPGA offer practical advantages in routine clinical settings. PQLI provides essential insight into patient-perceived disease burden, underscoring the importance of a multidimensional assessment approach. Integrating objective severity measures with patient-reported outcomes ensures comprehensive evaluation and optimal management of psoriasis.